SCHEMBL9734936

SCHEMBL9734936

CCCc1cc(CC(O)C(C)(C)C(=O)[O-])ccc1SCCCOc1ccc(C(C)=O)c(O)c1CCC.[Na+]

nearest known ligand 0.57

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG known ✓ P37231 5/20 0.57
CYSLTR1 known ✓ Q9Y271 11/20 0.49
PPARD Q03181 5/20 0.57
PPARA Q07869 5/20 0.57
CYSLTR2 Q9NS75 11/20 0.49
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
NFKB1 P19838 1/20 0.43
BLM P54132 1/20 0.43
GRM2 Q14416 1/20 0.43
PDE5A O76074 3/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
TBXAS1 P24557 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10922774 0.92 PPARG (0.56) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL10699760 0.92 PPARG (0.69) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL10697666 0.90 CYSLTR2 (0.53) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL9734876 0.83 PPARG (0.59) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL9733718 0.83 PPARG (0.73) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL9734933 0.82 CYSLTR2 (0.53) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL9733664 0.81 CYSLTR2 (0.56) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL10919586 0.78 CYSLTR2 (0.59) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL10919588 0.78 CYSLTR2 (0.59) PPARGPPARDPPARACYSLTR2CYSLTR1
SCHEMBL9734013 0.78 PPARG (0.70) PPARGPPARDPPARACYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed